Skip to main content
. 2022 Oct 19;8(11):e11183. doi: 10.1016/j.heliyon.2022.e11183

Figure 3.

Figure 3

(A) Hematoxylin and eosin-stained sections of tumours treated with Tam and vary fractions (200×). (B) Hematoxylin-eosin staining of breast tissue in normal mice (200×). (C) Body weight of each group. (D) Spleen/weight ratio of each group. ∗p < 0.05, ∗∗p < 0.01 vs TC (n = 8–10). (E) Hematoxylin-eosin staining of spleen (200×). (F) Hematoxylin-eosin staining of lung (200×).